Dividend Discount Model Formula: A Real-World Case Study for Investors

Dividend Discount Model Formula: A Real-World Case Study for Investors

The dividend discount model formula is P = D1 / (r - g), where P is the fair value per share, D1 is next year's expected dividend, r is the required rate of return, and g is the perpetual growth rate. Three inputs, one output. The formula is simple enough to calculate on a napkin, yet sensitive enough that a 1-percentage-point error in any input can shift the output by 20-40%. This case study applies the dividend discount model formula to a real dividend stock, step by step, so you can reproduce the process on any company in your watchlist.

Key Takeaways

• The dividend discount model formula is P = D1 / (r - g). Every term needs a defensible basis, not a guess.
• D1 is the current annual dividend multiplied by (1 + g). Getting the annualized base right is the first place analysts go wrong.
• The required return r is typically set using CAPM or a minimum hurdle rate of 9-12% for equity investments.
• Sensitivity analysis is not optional. Run the formula across a range of g and r values to understand the range of fair values, not just one point estimate.
• Johnson & Johnson (JNJ), with a 3.1% yield and 60+ year dividend streak, is the case study. The formula produces a base-case fair value of $144, with a range from $118 to $201 across plausible inputs.
• The formula fails for non-dividend payers and companies growing faster than the required return. Use a DCF model for those.

The Formula in Full

The Gordon Growth Model, the standard single-stage dividend discount model formula, is:

P = D1 / (r - g)

Expanded to show every step:

P = D0 x (1 + g) / (r - g)

Where:

• D0 = the most recently paid annual dividend per share
• g = estimated perpetual dividend growth rate (must be less than r)
• r = required rate of return on equity
• P = intrinsic value per share

The formula assumes dividends grow at a constant rate forever. That assumption is appropriate for companies that have demonstrated stable payout growth over at least one full economic cycle. It is inappropriate for high-growth companies, cyclicals, or firms in financial distress.

Step 1: Find the Current Annual Dividend (D0)

Johnson & Johnson (JNJ) as of April 2026:

• Most recent quarterly dividend: $1.19 per share
• Annualized: $1.19 x 4 = $4.76 per share

The annualization step is where many investors err. Some data providers show only the quarterly figure. Some show a trailing 12-month total that differs from the current quarterly rate if there was a mid-year increase. Use the most recent quarterly payment multiplied by four as your D0. It represents the current run rate, which is what the formula needs.

JNJ has raised its quarterly dividend every year since 1963. The consistency matters because the formula assumes the current dividend is the starting point for perpetual growth.

Step 2: Estimate the Long-Run Growth Rate (g)

The growth rate is the most sensitive input. A 1-percentage-point change in g changes the output more than a 1-point change in r at typical yield levels.

Three approaches to estimating g for JNJ:

Historical dividend CAGR. Over the past 10 years, JNJ has grown its dividend from $2.80 to $4.76, a CAGR of approximately 5.5%. Over the past 5 years the CAGR is 5.9%. Anchoring g at 5.5% is defensible.

Sustainable growth rate. Sustainable growth = ROE x retention ratio. JNJ's ROE runs near 22% and the payout ratio is approximately 43%, implying a retention ratio of 57%. Sustainable growth = 22% x 0.57 = 12.5%. This is far above the 5.5% historical dividend CAGR because JNJ also uses retained earnings for acquisitions and buybacks, not just dividend growth. In this case the sustainable growth formula overstates what is available for dividends.

Analyst consensus. Dividend growth consensus for JNJ over the next 5 years runs near 5-6%, consistent with the historical figure.

Selected g for this case study: 5.5%

Step 3: Set the Required Rate of Return (r)

Using CAPM: r = risk-free rate + (beta x equity risk premium)

• U.S. 10-year Treasury yield as of April 2026: 4.4%
• JNJ beta: approximately 0.55 (defensive healthcare company)
• Equity risk premium: 5.0%

r = 4.4% + (0.55 x 5.0%) = 4.4% + 2.75% = 7.15%

This CAPM output seems low for an equity investment. Many value investors set a floor. At ValueMarkers, we typically use 8-9% for investment-grade consumer staples and healthcare names with JNJ's balance sheet quality, regardless of what CAPM says. The floor rate acknowledges that CAPM beta is a backward-looking volatility measure, not a forward-looking business risk measure.

Selected r for this case study: 9.0%

Step 4: Apply the Dividend Discount Model Formula

With D0 = $4.76, g = 5.5%, r = 9.0%:

• D1 = $4.76 x (1 + 0.055) = $4.76 x 1.055 = $5.02
• P = $5.02 / (0.090 - 0.055) = $5.02 / 0.035 = $143.43

JNJ traded near $153 as of April 2026. The base-case DDM suggests the stock is priced roughly at fair value, with a slight premium of about 7%.

Step 5: Sensitivity Analysis

One number is not an answer. The DDM formula produces a range of estimates depending on the inputs. The table below shows how the fair value changes across plausible growth and discount rate combinations.

The base-case assumption of g = 5.5% and r = 9.0% gives $143.43 (table shows approximate $150.53 due to rounding in D1). The fair value range across this grid runs from $90 to $235. That is a wide range, but the scenarios in the lower-left corner (high g, low r) require you to believe JNJ grows dividends at 6% forever while you require only 8% return, which is not a realistic combination. The realistic range clusters in the center of the table, roughly $118 to $167 across the most defensible input combinations.

JNJ at $153 sits within that realistic range, suggesting the market is pricing it fairly with no obvious margin of safety.

Two-Stage DDM: Accounting for Near-Term Growth

JNJ is transitioning from a pharmaceutical and consumer goods conglomerate to a more focused pharmaceutical and medical devices company following the Kenvue spinoff. Near-term growth may differ from the long-run terminal rate. A two-stage DDM captures this.

Assumptions:

• Phase 1 (years 1-7): g = 6.0% (reflecting Pharmaceutical pipeline strength)
• Phase 2 (year 8+): g = 4.5% (terminal rate, more conservative)
• r = 9.0% throughout

The two-stage model produces $120.62, below the single-stage result of $143. The difference comes from the more conservative terminal growth rate of 4.5% versus 5.5%. This is not necessarily the "right" answer. It shows you how the answer depends on which phase matters most and what you assume for the long run. At JNJ's current price of $153, both models say you are paying at least fair value, with no obvious safety margin on the dividend discount model formula alone.

What the Formula Cannot Tell You

The DDM formula answers one specific question: what is this dividend stream worth at my required return and assumed growth rate? It does not tell you:

• Whether the dividend is safe. JNJ's payout ratio of 43% and free cash flow coverage above 2x suggest it is. For a company with a 90% payout ratio, the formula's output is only as reliable as the payout itself.
• Whether the business is good. A high-quality business with a low-quality balance sheet can produce a mathematically valid DDM output and still be a poor investment. Check our screener for ROIC, debt-to-equity, and VMCI Quality scores alongside any DDM work.
• Whether you should buy it. The DDM is a valuation input, not a buy signal. Compare the DDM output to the current price, check the margin of safety, and triangulate with an earnings-based or free cash flow model.

For stocks that do not pay dividends, like MSFT (P/E 32.1, which pays a token dividend of under 1%), or AAPL (ROIC 45.1%, P/E 28.3, minimal dividend relative to earnings), the DDM is the wrong formula entirely. Use our DCF calculator for those.

How This Formula Fits the VMCI Framework

At ValueMarkers, we score every stock on the VMCI Scale: Value (35%), Quality (30%), Integrity (15%), Growth (12%), Risk (8%). The DDM formula feeds the Value pillar directly. A stock trading at a 20% discount to its DDM fair value scores higher on Value than one trading at a 20% premium, all else equal.

The Quality pillar evaluates whether the dividend is reliable enough to be modeled. JNJ's 60+ year consecutive increase history, payout ratio below 50%, and free cash flow coverage well above 1x gives it one of the highest Quality sub-scores among large-cap healthcare names. High Quality scores validate the DDM inputs. Low Quality scores mean the assumed perpetual growth rate is questionable.

Further reading: Investopedia · CFA Institute

Why gordon growth model formula Matters

This section anchors the discussion on gordon growth model formula. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply gordon growth model formula in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.

Key inputs for gordon growth model formula

See the main discussion of gordon growth model formula in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using gordon growth model formula alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.

Sector benchmarks for gordon growth model formula

See the main discussion of gordon growth model formula in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using gordon growth model formula alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.

Related ValueMarkers Resources

• Enterprise Value to EBITDA (EV/EBITDA) — Enterprise Value to EBITDA is the metric used to how cheaply a stock trades relative to its fundamentals
• DCF Intrinsic Value — DCF captures how cheaply a stock trades relative to its fundamentals
• Enterprise Value to Free Cash Flow (EV/FCF) — Enterprise Value to Free Cash Flow captures how cheaply a stock trades relative to its fundamentals
• Dividend Discount Model — related ValueMarkers analysis
• Ddm Model — related ValueMarkers analysis
• Vanguard Retirement Calculator — related ValueMarkers analysis

Frequently Asked Questions

how to work out dividend yield

Dividend yield equals annual dividends per share divided by current share price, expressed as a percentage. Annualize quarterly dividends by multiplying by four before dividing by price. JNJ at $4.76 annual dividend and a $153 price gives 4.76 / 153 = 3.1%. This yield is the market's current pricing of the dividend stream; the DDM formula tells you what that stream is worth at your own required return.

what is a dividend stock

A dividend stock is a share in a company that distributes a regular portion of earnings to shareholders as cash. JNJ and KO are the clearest examples: both have paid uninterrupted and growing dividends for 60+ years. Companies like MSFT (P/E 32.1) pay a small dividend as a secondary capital return mechanism. High-growth companies often pay nothing, choosing to reinvest all earnings into the business instead.

how to calculate dividend payout

Dividend payout ratio = dividends per share / earnings per share. JNJ's payout ratio runs near 43%, meaning it retains 57% of earnings. A ratio below 60% is generally safe through an earnings downturn. A ratio above 90% signals the dividend is vulnerable to a cut if earnings miss expectations. For the DDM formula to be reliable, the payout ratio should have room to sustain the dividend through a moderate earnings recession.

how to pick a dividend stock

Start with consistency: look for at least 10 consecutive years of uninterrupted dividend payments. Then check coverage: payout ratio below 65%, free cash flow per share above 1.2 times the annual dividend. Then value: apply the DDM formula and confirm the current price does not require an implausibly high growth assumption to justify. The ValueMarkers screener lets you filter all three simultaneously across 10,000+ stocks.

what is financial leverage ratio formula

The financial leverage ratio most commonly used is total assets divided by shareholders' equity. A ratio of 3 means the company has $3 in assets for every $1 of equity, with the rest funded by debt. For dividend investing, high debt ratios are a warning sign because debt service competes with dividend payments. JNJ carries a relatively low debt ratio of approximately 2.1x, consistent with its investment-grade credit rating and reliable dividend history.

what does dividend yield mean

Dividend yield is the annual income return you receive per dollar invested in a stock. A 3.1% yield on JNJ means every $100 invested at the current price generates $3.10 per year in dividends before tax. Yield moves inversely with price: if JNJ falls 10% and the dividend stays flat, the yield rises to 3.44%. This inverse relationship is why a rising yield on a stable business can signal a buying opportunity, while a rising yield on a deteriorating business often signals a payout cut is coming.

Apply the dividend discount model formula to your own watchlist using the ValueMarkers DCF calculator, which supports Gordon Growth and two-stage DDM inputs alongside full free cash flow models.

Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.

Ready to find your next value investment?

ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.

Related tools: DCF Calculator · Methodology · Compare ValueMarkers

Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.